13F Pro Quality Score

56.5/100

Rank #1,098 of 2,879 stocksTOP 50%

View Materials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

19.1/100

Profitability

67.6/100

Balance Sheet

84.1/100

Earnings Quality

41.6/100

Free Cash Flow

57.6/100

Institutional Flow

28.7/100

Revenue Scale

72.8/100

Dilution Risk

68.8/100

CBT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CABOT CORP (CBT), a Materials sector company. 13F Pro's AI-powered ranking engine scores CBT at 56.5/100 on a 32-signal composite quality model, placing it at rank #1,098 of 2,879 stocks — the top half of the AI-ranked universe. CBT scores in the top quartile across balance sheet strength (84.1). Areas of concern include revenue growth (19.1) and institutional flow (28.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), CABOT CORP reports quarterly revenue of $904.0M, net income of $68.0M, an operating margin of 14.3%. Top institutional holders of CBT by reported 13-F value include BlackRock,, WELLINGTON MANAGEMENT GROUP LLP, EARNEST PARTNERS, based on the most recent SEC filings. CBT trades on the NYSE exchange and files with the SEC under CIK 16040. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CBT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CABOT CORP directly from SEC EDGAR. CABOT CORP's 13F Pro composite quality score has ranged between 8 and 67 since 2021, currently 56.5 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about CABOT CORP

Quirks, history, and lore behind CBT — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. specialty chemicals company · mid-cap · listed on the NYSE · headquartered in Massachusetts.
  • 2
    The Numbers
    Annual revenue in the range of $3–4 billion, with operations spanning multiple continents — selling to industries you use every day but never think about.
  • 3
    The History
    Founded in the late 1800s, it built its early fortune on carbon black — the sooty stuff that makes tires black and keeps them from falling apart after 100 miles.
  • 4
    The Secret
    It has quietly expanded beyond carbon black into activated carbon for water purification and specialty fluids, making it an unglamorous but essential corner of the materials world.
  • 5
    The Lore
    Its carbon black ends up in roughly 70% of all rubber tires globally — meaning every car on the road is almost certainly rolling on a little piece of this company.
  • 6
    The Giveaway
    A Boston-based specialty chemicals giant named after its founding family, its three-letter ticker is as compact as the carbon particles it's been selling since the 1880s.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$904.0M

Net Income

Q2 2026

$68.0M

Free Cash Flow

Q2 2026

$32.0M

Operating Margin

Q2 2026

14.3%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-7.0% YoY
$3.71BFY 2025
FY22 $4.32BFY23 $3.93BFY24 $3.99BFY25 $3.71B

Net Income

-12.9% YoY
$331.0MFY 2025
FY22 $209.0MFY23 $445.0MFY24 $380.0MFY25 $331.0M

Operating Income

+1.1% YoY
$621.0MFY 2025
FY22 $389.0MFY23 $526.0MFY24 $614.0MFY25 $621.0M

EPS (Diluted)

-10.4% YoY
$6.02FY 2025
FY22 $3.62FY23 $7.73FY24 $6.72FY25 $6.02

Total Assets

+2.1% YoY
$3.81BFY 2025
FY22 $3.52BFY23 $3.60BFY24 $3.74BFY25 $3.81B

Total Debt

+19.8% YoY
$1.37BFY 2025
FY22 $1.44BFY23 $1.28BFY24 $1.14BFY25 $1.37B

Op. Cash Flow

-3.9% YoY
$665.0MFY 2025
FY22 $100.0MFY23 $595.0MFY24 $692.0MFY25 $665.0M

AI Insight: CBT Financial Trends

Revenue has declined six consecutive quarters from $1,016M to $904M while net income has nearly halved, signaling a meaningful deterioration in top-line and earnings momentum.

Revenue fell from $1,016M in Q2 2024 to $904M in Q1 2026, a six-quarter slide of roughly 11%.

Net income dropped sharply from $137M in Q3 2024 to $68M in Q1 2026, a 50% decline over five quarters.

Operating income compressed from $172M in Q2 2024 to $129M in Q1 2026, with op margin narrowing meaningfully.

Equity grew from $1,346M in Q2 2024 to $1,568M in Q1 2026, a modest balance-sheet positive amid earnings pressure.

Total debt rose to $1,299M in Q1 2026 from $1,140M in Q2 2024 while earnings weakened — leverage is rising.

Operating cash flow remains volatile, swinging from $249M in Q2 2025 to just $77M in Q1 2026.

Q4 2025 debt drop to $1,126M followed by a Q1 2026 rebound to $1,299M — debt management consistency is unclear.

AI Insight: CBT Ratio Trends

Cabot's profitability has deteriorated markedly since mid-2024, with ROIC falling from 27.7% in Q2 2024 to 18.0% in Q1 2026.

ROIC has contracted nearly 10 percentage points, from 27.7% in Q2 2024 to 18.0% in Q1 2026.

Operating margin slipped to 14.3% in Q1 2026, the lowest in the observed period, down from a peak of 18.1% in Q2 2025.

Net profit margin collapsed to 4.8% in Q3 2025 before partially recovering to 7.5% in Q1 2026, signaling one-off or volatile earnings.

D/E ratio improved to 0.71 in Q4 2025 but rebounded to 0.83 in Q1 2026, showing no sustained deleveraging trend.

ROIC at 18.0% in Q1 2026 is the lowest single-quarter reading in the dataset — monitor whether this floor holds.

The Q3 2025 NPM drop to 4.8% warrants scrutiny; if the underlying cause recurs, earnings quality is at risk.

D/E briefly dipped to 0.71 in Q4 2025 then rose back to 0.83 — watch for a sustained leverage reduction.

Get alerted when CBT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CABOT CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CBT

Put CBT on your watchlist

Track score changes the day CABOT CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CBT a good stock to buy?

13F Pro's AI-powered analysis of CABOT CORP (CBT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CBT are available on the CBT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CBT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CBT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CABOT CORP's investment landscape.